Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Join Bachem for a Virtual Event on Tuesday, December 5th, 2023.
Released By Bachem
November 22, 2023
Abstract: Throughout industry the trend goes from producing batches to continuous production. Due to the increasing need for efficient methods to produce peptides and oligonucleotides on a large scale, Bachem was the first TIDES manufacturer to introduce Multicolumn Countercurrent Solvent Gradient Purification (MCSGP) systems for their continuous purification. Now being able to purify faster and very sustainably tens of kilograms of TIDES under GMP conditions, the company’s leading technologist in this field explains along with two of the fathers of this technology, Prof. Morbidelli and Thomas Müller-Späth, what makes MCSGP the new industry standard. CLICK HERE TO REGISTER NOW >>>>> Speakers: RALF EISENHUTH PH.D. Principal Process Manager Chromatography With a Ph.D. in organic chemistry from the University of Karlsruhe, Ralf Eisenhuth joined Bachem AG in 2008. Over the last decade, he held several positions at Bachem: ranging from process development to leading the large-scale purification of peptides at the Bubendorf site. In his current position as Process Manager of Chromatography and Technology Transfer, he is focusing on innovative purification technologies and processes. He is an inventor on several patents. ———– KEITH PORTER Business Development Manager Keith Porter studied Organic Chemistry and Materials Science at the University of Illinois UrbanaChampaign. Keith has more than ten years of research and development experience in the field of solid-phase peptide synthesis (SPPS) and spent most of his career striving to improve this technique. In 2021, he joined Bachem as Business Development Manager. Keith published several scientific articles during his career. ———– PROF. MASSIMO MORBIDELLI Cofounder ChromaCon AG Massimo Morbidelli received his Laurea in Chemical Engineering at the Polytechnic University of Milan and PhD at the University of Notre Dame. Currently, he is Professor Emeritus at the ETH Zurich and at the Polytechnic University of Milan and a member of the Italian Academy of Sciences (Accademia dei Lincei). Furthermore, he is the recipient of the ERC Advanced Grant on Continuous Digitalized Bioprocesses (CoDiBio). His main research interests are biopharmaceutics, the integrated continuous manufacturing of therapeutic proteins, and its automation and digitalization. He is co-author of more than 750 papers, 23 international patents, and 6 books. He is a cofounder of ChromaCon Ltd., a spin-off company from his research group, now acquired by YMC, Japan. ———– THOMAS MÜLLER-SPÄTH, PH.D. CEO and Cofounder of ChromaCon AG Thomas Müller-Späth, Dr. sc. ETH, Dipl.-Ing., is CEO and co-founder of ChromaCon AG, a YMC company. Thomas studied Chemical Engineering at the Technical University of Hamburg, and at the University of California, Berkeley. In 2008, he obtained his Ph.D. for investigating multi‑column technology for the purification of proteins at the Swiss Federal Institute of Technology (ETH Zurich) in the group of Prof. Morbidelli. He is an inventor on several patents, and author of numerous scientific articles on continuous chromatography for biopharmaceuticals. CLICK HERE TO REGISTER NOW >>>>>
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !